ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Novel Platform For Execution Of Pragmatic Studies Boosts Cancer Trial Efficiency

  Learn how Flatiron partnered with Genentech and Foundation Medicine to develop a novel platform for the execution of pragmatic studies.

• Let's Talk About The TMF Trinity

  Explore the three things that all studies try to achieve with their trial master file, and how the accelerated usage of the eTMF helps to both manage and meet these expectations.

• Advancing Neuromuscular Research with Digital Endpoints

  Explore cutting-edge digital measures that capture peak mobility and activity in real-world settings, offering meaningful insights into disease progression in neuromuscular disorders.

• Want To Make Your Trial More Patient-Centric? Here's An eCOA For That

  Electronic clinical outcome assessments transform the paper-based evaluation into a real-time digital tool that collects insights directly from the patient. Explore how this brings several immediate benefits.

• Reflections From ISOQOL Conference 2024

  Greta van Schoor attended the 31st Annual ISOQOL Conference, where HRQOL leaders shared insights on optimizing eCOA collection, integrating PROs, and digital health in clinical research.

• Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases

  Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.

• Maximize The Value Of Wearable Data

  Explore this near real-time adherence monitoring solution for clinical trial sponsors that compares wearable device data collected from a participant's scheduled activities and visit dates.

• Moving Towards AI, ML, And Trial Platforms For True Scalability

  Uncover why AI, ML, and clinical trial platforms have the potential to create true scalability across an organization's entire pipeline, and reduce timelines by YEARS.

• Navigating The eCOA Vendor Landscape In 2025

  This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.

• From Data Delays To Decision Speed

  The biggest risk in modern trials isn’t missing data. It’s delayed insight. Discover how real-time intelligence helps teams act faster, reduce risk, and improve trial execution.